[{"id":"f965bbc3-93ee-4cad-a883-6038cf35ab84","acronym":"","url":"https://clinicaltrials.gov/study/NCT05210868","created_at":"2022-01-29T18:04:53.789Z","updated_at":"2024-07-02T16:36:17.861Z","phase":"Phase 1/2","brief_title":"A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)","source_id_and_acronym":"NCT05210868","lead_sponsor":"Beijing InnoCare Pharma Tech Co., Ltd.","biomarkers":" CD20","pipe":" | ","alterations":" CD20 expression","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PRO-203"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 184","initiation":"Initiation: 11/16/2021","start_date":" 11/16/2021","primary_txt":" Primary completion: 12/28/2026","primary_completion_date":" 12/28/2026","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2022-01-27"}]